Level Up Smoke & Tobacco Shop Fined $3K in unlicensed cannabis case
D.C. regulators finalized enforcement action against Level Up Smoke & Tobacco Shop, an unlicensed cannabis retailer that was previously shut down in a coordinated raid, settling the case with a $3,000 fine after the business accepted violations through an offer-in-compromise; under the agreement, any future violations will trigger a significantly higher $10,000 penalty.
- The next ABC Board meeting is May 13 : watch, agenda.
- Catch up on the May 6 disposition.
- ABCA is currently recruiting for a high-level Human Resources Specialist to oversee agency staffing and compliance.
- Higher Ground medical dispensary continues to get media coverage as the “East Coast’s largest cannabis lounge.”
FBI raids office and cannabis business of Senate leader Louise Lucas
FBI agents executed search warrants on May 6, 2026, at the Portsmouth office and a co-owned hemp-THC retailer, The Cannabis Outlet, belonging to Senate President Pro Tempore L. Louise Lucas. Part of a long-running corruption probe, the investigation is reportedly examining potential “pay-to-play” allegations involving the intersection of Lucas’s legislative influence and her private cannabis interests. Senator Lucas dismissed the raids as “political intimidation” linked to her redistricting stances, returning to her legislative duties the following day. However, this federal scrutiny arrives at a delicate moment for the Commonwealth, as Governor Spanberger and lawmakers remain deadlocked over the official launch of Virginia’s adult-use retail market.
Federal Court Tosses Hemp Industry Lawsuit Against Maryland Cannabis Reform Act
A federal court has dismissed a hemp industry lawsuit challenging Maryland’s Cannabis Reform Act, effectively upholding the state’s authority to require licensing for the sale of intoxicating hemp-derived products and reinforcing earlier rulings that these products can be regulated or restricted under state cannabis laws without violating federal protections for hemp.
- Maryland union files federal charges against TerrAscend over alleged anti-union tactics
ICYMI: D.C. Cannabis Board Locks in Forced Sale Terms After Fenwick Street Cultivator Closure
East Coast Roundup
New York regulators have begun accepting applications for cannabis farmers’ markets and pop-up events, expanding short-term retail opportunities for licensed operators to reach consumers outside traditional dispensary channels.
Connecticut lawmakers moved to reinstate THC potency caps on cannabis flower, signaling renewed regulatory tightening that could impact product formulation and pricing for in-state cultivators and retailers.
New Hampshire’s cannabis program is experiencing continued growth and operational expansion, reflecting increasing participation and momentum in the state’s medical or regulated cannabis framework.
Establishing a cannabis control board in Pennsylvania could serve as a structural stepping stone toward future recreational cannabis legalization.
North Carolina lawmakers are advancing a bill aimed at placing cannabis legalization on the 2026 ballot, indicating a potential shift toward voter-driven cannabis policy reform in the state.
Culture & More
The New York Times reviews emerging research and expert perspectives on cannabis health risks, emphasizing potential concerns around regular use, mental health effects, and broader public health implications.
Cannabis breeders are innovating new growth patterns and traits beyond traditional strains involving unusual or “mutant” plant genetics.
Following federal rescheduling discussions, Tilray is signaling renewed interest in expanding into the U.S. cannabis market, suggesting potential strategic shifts among large multi-state or international operators.
Around the Country
An Ohio court is hearing arguments over whether to block newly proposed restrictions on hemp-derived products, reflecting ongoing legal battles over how intoxicating hemp should be regulated.
California’s mature cannabis market continues to face economic pressure, including high taxes, strict regulation, and intense competition among dispensaries.
Potential federal rescheduling of cannabis could significantly impact Nevada’s industry, particularly in areas like taxation, banking access, and regulatory alignment.
A class-action lawsuit filed in Illinois alleges that major cannabis companies systematically market THC products with misleading or unsupported claims that they can treat conditions like anxiety, depression, PTSD, and pain, despite lacking FDA approval or sufficient scientific evidence.
From the swamp
Opponents of cannabis reform have filed a federal lawsuit arguing that the Trump administration’s move to reschedule cannabis from Schedule I to Schedule III violates the Administrative Procedure Act and exceeds statutory authority, claiming the change was improperly adopted and should be blocked or overturned by the court.
